Rates of prostate specific antigen (PSA) test ordering vary considerably among GPs1 and, contrary to international recommendations,2 PSA tests are performed on non-symptomatic males, either at a patient’s request or offered by the GP as opportunistic screening for prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.